Vanguard Group Inc Veracyte, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,748,514 shares of VCYT stock, worth $318 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,748,514

Previous 7,496,981 3.36%

Holding current value

$318 Million

Previous $162 Million 62.31%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $5.28 Million - $8.87 Million	251,533 Added 3.36%	7,748,514 $264 Million
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $2.11 Million - $2.64 Million	112,110 Added 1.52%	7,496,981 $162 Million
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $5.6 Million - $7.76 Million	266,660 Added 3.75%	7,384,871 $164 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $1.04 Million - $1.51 Million	52,699 Added 0.75%	7,118,211 $196 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $477,527 - $639,839	21,385 Added 0.3%	7,065,512 $158 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $735,800 - $947,483	35,105 Added 0.5%	7,044,127 $179 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $3.22 Million - $4.36 Million	156,365 Added 2.28%	7,009,022 $156 Million
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $1.48 Million - $2.89 Million	96,666 Added 1.43%	6,852,657 $163 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $863,768 - $1.45 Million	52,097 Added 0.78%	6,755,991 $112 Million
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $1.47 Million - $2.8 Million	94,988 Added 1.44%	6,703,894 $133 Million
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $297,550 - $576,520	13,562 Added 0.21%	6,608,906 $182 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $1.52 Million - $2.26 Million	42,019 Added 0.64%	6,595,344 $272 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $10.1 Million - $15 Million	283,076 Added 4.51%	6,553,325 $304 Million
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $207 Million - $355 Million	6,270,249 New	6,270,249 $251 Million

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Veracyte, Inc. Transaction History